Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: 5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Grant | Utility: Quinazolines as potassium ion channel inhibitors Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Antibodies to TIGIT Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Piperidinone formyl peptide 2 receptor agonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase and/or EPX Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Application | Utility: USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Libraries of modified fibronectin type III tenth domain-containing polypeptides Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Imaging methods using 18F-radiolabeled biologics Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Application | Utility: Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: Anti-LAG-3 Antibodies to Treat Hematological Malignancies Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: METHODS OF AAV THERAPY Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: METHODS OF PURIFYING PROTEINS USING CHROMATOGRAPHY Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: FEBRIFUGINE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Application | Utility: MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: METHODS OF TREATMENT USING CTLA4 MOLECULES Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: Biaryl kinase inhibitors Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHE- NYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH) Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same Filling date: 6 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 6 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: 3-substituted propionic acids as .alpha.V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Tricyclic sulfones as ROR.sub..gamma. modulators Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: TL1A antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: COMPOUNDS USEFUL AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Selective NR2B antagonists Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: TGF beta receptor antagonists Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Application | Utility: [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: CYCLOHEXYL ACID PYRAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: Pyrazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Grant | Utility: Substituted naphthyridinone compounds useful as T cell activators Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Selective NR2B antagonists Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Bispecific EGFR/IGFIR binding molecules Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Application | Utility: PROCESS FOR PREPARING TETRAHYDROCARBAZOLE CARBOXAMIDE COMPOUND Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: CYCLOHEXYL ACID PYRAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NON-CHROMATOGRAPHIC PURIFICATION OF MACROCYCLIC PEPTIDES BY A RESIN CATCH AND RELEASE Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ARYL HETEROCYCLIC PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Showing 300 to 350 of 772 patents.